UVV Universal Corporation
Universal Corporation, a business-to-business agriproducts company, provides leaf tobacco and plant-based ingredients to food and beverage end markets worldwide. The company operates in two segments, Tobacco Operations and Ingredients Operations. The Tobacco Operations segment is involved in procuring, processing, packing of flue-cured, burley, dark air-cured, and oriental leaf tobacco for consumer product manufacturers, as well as provision of related services. This segment also offers specialty services, such as custom blending, chemical and physical testing of tobacco, service cutting, reconstituted leaf tobacco manufacturing, and just-in-time product delivery services; and liquid nicotine for tobacco products manufacturers, as well as recycled waste materials from tobacco production. The Ingredients Operations segment engages in the production of specialty plant-based ingredients, including fruits, vegetables, herbs, fruit and vegetable juices, concentrates, pomaces, ciders, purees, nutraceuticals, fruit fibers, seeds, seed powders, dehydrated products, botanical extracts, distillates, natural flavors, colors, and other value-added products for consumer-packaged goods manufacturers and retailers, as well as food, and beverage companies. The company was founded in 1918 and is headquartered in Richmond, Virginia.…
Industry Peers
TobaccoKey Statistics
About Universal (NYSE: UVV)
›
Universal (NYSE: UVV) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Tobacco industry, part of the Consumer Defensive sector, and reports about 11,250 employees.
The shares were at 32.23 USD on 20 November 2026, down 36.3% over 52 weeks. Its 52-week range is 32.19 USD to 59.38 USD, and it trades at the bottom of that range.
Its market capitalisation is 803.40M USD. It pays a dividend yielding 10.07%, against a median of 5.50% among the dividend payers in that peer group.
Universal reports return on equity of 2.3%, an operating margin of 5.5% and revenue down 17.5% year over year.
Its debt exceeds its cash by 1.18B USD, a debt-to-equity ratio of 0.66. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. One analyst covers the stock; their mean price target of 60.00 USD is 86.2% above the current price. The next earnings report is expected on 9 February 2027.